Iron Gate Global Advisors’s Novo Nordisk NVO Stock Holding History

Iron Gate Global Advisors’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-5,888	Closed	-$216K	–	113
2026 Q1	$216K	Buy	+5,888	New	+$279K	0.02%	99
2024 Q4	–	Sell	-2,266	Closed	-$270K	–	94
2024 Q3	$270K	Sell	2,266 -200	-8%	-$26.7K	0.04%	72
2024 Q2	$352K	Buy	2,466 +56	+2%	+$7.42K	0.06%	63
2024 Q1	$307K	Buy	2,410 +214	+10%	+$25.5K	0.05%	76
2023 Q4	$227K	Buy	+2,196	New	+$217K	0.04%	88
2021 Q3	–	Sell	-5,544	Closed	-$232K	–	121
2021 Q2	$232K	Buy	+5,544	New	+$215K	0.07%	94

Other funds holding NVO

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Iron Gate Global Advisors's NVO Position: Q2 2026 in Review

Iron Gate Global Advisors sold out of Novo Nordisk (NVO) in Q2 2026, closing a stake of 5,888 shares — an estimated $216K sold.

Iron Gate Global Advisors first reported a position in NVO in Q2 2021 and held it in 6 quarters. The position peaked at $352K in Q2 2024. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

Iron Gate Global Advisors reported no remaining Novo Nordisk position as of Q2 2026 after selling out during the quarter.
Iron Gate Global Advisors sold 5,888 Novo Nordisk shares in Q2 2026, an estimated $216K.
Iron Gate Global Advisors first reported a position in Novo Nordisk in Q2 2021 and held it in 6 quarters.
Iron Gate Global Advisors's Novo Nordisk position peaked at $352K in Q2 2024.
1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Iron Gate Global Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.